Next Generation Therapeutics

Next Generation Therapeutics (NGT) is a biotechnology company dedicated to the discovery and development of transformative treatments for neurodegenerative diseases, with a primary focus on Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Founded by industry veterans with extensive experience in drug discovery and development, the company leverages a proprietary platform to identify novel therapeutic targets and develop small molecule and gene therapy candidates. NGT operates with a dual model, advancing its internal pipeline of CNS-focused programs while also providing specialized drug discovery and development services through its NGT BioPharma Solutions division. The company's mission is to accelerate the delivery of life-changing medicines to patients suffering from devastating neurological conditions by combining cutting-edge science with efficient operational execution.